FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention refers to pharmaceutical industry, namely to an aqueous pharmaceutical composition for treating type 1 or type 2 diabetes mellitus. Aqueous pharmaceutical composition for treating type 1 diabetes mellitus or type 2 diabetes mellitus contains 200–500 units/ml of insulin glulisin, methionine, zinc in effective concentrations and does not contain chloride. Method of treating type 1 diabetes mellitus or type 2 diabetes mellitus. Use of an aqueous pharmaceutical composition for preparing a medicinal agent for treating type 1 diabetes mellitus or type 2 diabetes mellitus. Medical device for treating type 1 diabetes mellitus or type 2 diabetes mellitus.
EFFECT: disclosed aqueous pharmaceutical composition is stable at high temperatures.
27 cl, 2 dwg, 4 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TREATING DIABETES MELLITUS WITH LONG-ACTING INSULIN FORMULATIONS | 2014 |
|
RU2705797C2 |
| COMPOSITIONS OF LONG-TERM ACTION INSULINS | 2015 |
|
RU2642662C2 |
| STABILIZED PHARMACEUTICAL COMPOSITIONS OF INSULIN ANALOGUES AND/OR INSULIN DERIVATIVES | 2014 |
|
RU2702345C2 |
| COMPOSITIONS OF LONG-ACTING INSULIN | 2011 |
|
RU2564104C2 |
| ZINC-FREE AND ZINC-DEPLETED INSULIN COMPOSITIONS OF INCREASED STABILITY | 2002 |
|
RU2311922C2 |
| ACID INSULIN PREPARATIONS WITH ENHANCED STABILITY | 2003 |
|
RU2313362C2 |
| RAPIDLY FIXED DOSAGE FORMS OF INSULIN | 2010 |
|
RU2506945C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING AGONIST GLP-1, INSULIN AND METHIONINE | 2010 |
|
RU2537239C2 |
| CARBOHYDRATE-CONTAINING INSULIN PREPARATIONS | 1997 |
|
RU2204411C2 |
| STRAIN OF ESCHERICHIA COLI BACTERIA WITH REDUCED ABILITY TO ACCUMULATE ACETATE - PRODUCER OF HYBRID POLYPEPTIDE CONTAINING PROINSULIN GLARGINE | 2023 |
|
RU2807548C1 |
